Applying the International Classification of Functioning-Children and Youth Version to Pediatric Neuro-oncology

Thomas Pletschko1, Anna Felnhofer1, Agathe Schwarzinger1

  • 11 Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Insights

The International Classification of Functioning-Children and Youth version (ICF-CY) framework helps assess functional limitations in pediatric brain tumor survivors. This aids in personalized care and improved long-term outcomes for these young patients.

Area of Science:

  • Pediatric Neuro-oncology
  • Rehabilitation Medicine
  • Disability Studies

Background:

  • Increased survival rates in pediatric central nervous system tumors highlight the need to address late effects.
  • Neurologic sequelae, neuropsychological deficits, and social difficulties are significant concerns in follow-up care.
  • Assessing cognitive impairments alone is insufficient for personalized treatment recommendations.

Purpose of the Study:

  • To introduce the International Classification of Functioning-Children and Youth version (ICF-CY) as a framework for quantifying functional limitations.
  • To inform long-term care strategies for pediatric neuro-oncology patients.
  • To provide recommendations for clinical practice based on ICF-CY core sets.

Main Methods:

  • Conceptual framework introduction: ICF-CY.
  • Discussion of a standardized self-report and proxy-report questionnaire for participation measurement.
  • Development of recommendations based on ICF-CY core sets for clinical practice.

Main Results:

  • The ICF-CY provides a comprehensive approach to assessing functional limitations in pediatric brain tumor survivors.
  • A standardized questionnaire aids in measuring participation in daily social activities.
  • Core sets derived from the ICF-CY can guide clinical practice.

Conclusions:

  • The ICF-CY framework is essential for a holistic assessment of pediatric brain tumor survivors.
  • Quantifying functional deficiencies alongside cognitive impairments is crucial for personalized care.
  • Implementing ICF-CY-based recommendations can improve long-term management and outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
210
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
196
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
154
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
173
Nursing Interventions II: Selecting and Classifying the Nursing Interventions01:29

Nursing Interventions II: Selecting and Classifying the Nursing Interventions

Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
3.0K
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K